Experienced in Hyperaldosteronism

Marcus M. Lind

Goeteborg, O, SE 
Experienced in Hyperaldosteronism
Goeteborg, O, SE 
OverviewLocationsClinical Research

Overview

Marcus Lind practices in Goeteborg, Sweden. Mr. Lind is rated as an Experienced expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), and Wilson Disease.

His clinical research consists of co-authoring 177 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hyperaldosteronism.

Gender
Male

Locations

Goeteborg, O, Sweden
Other Locations
Umea, AC, Sweden
Uddevalla, O, Sweden
Skelleftea, AC, Sweden
Trollhaettan, O 45180, Sweden
Sweden
Department Of Forest Mycology And Plant Pathology, Uppsala, C 75007, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® (Insulin Aspart Injection)
Enrollment Status: Completed
Publish Date: June 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Accuracy of Two CGM Systems Tested Simultaneously in Ambulatory Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: December 19, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

177 Total Publications

Accuracy of Glucose Trends by Subcutaneous Continuous Monitoring vs Intermittent Arterial Measurements in Critically Ill Patients.
Accuracy of Glucose Trends by Subcutaneous Continuous Monitoring vs Intermittent Arterial Measurements in Critically Ill Patients.
Journal: Journal of diabetes science and technology
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lind's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile